LAPSES IN ASTHMA CONTROL IN PATIENTS WHO CONTINUED VS. DISCONTINUED OMALIZUMAB IN A REAL-WORLD SETTING.

被引：0
|
作者：
Sun, G.
Antonova, E.
Chang, E.
Broder, M.
Solari, P.
Zazzali, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2014年 / 113卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P80
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [31] Baseline Characteristics Of Patients With Asthma Treated With Dupilumab In A Real-World Setting: The RAPID Registry
    Lugogo, Njira
    Soler, Xavier
    Menzies-Gow, Andrew
    Peters, Anju
    Cote, Andreanne
    Hilberg, Ole
    Xia, Changming
    Zhang, Yi
    Gomez, Lucia De Prado
    Rowe, Paul
    Radwan, Amr
    Jacob-Nara, Juby
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB21 - AB21
  • [32] Real-world treatment patterns of adult multiple myeloma patients treated with carfilzomib in the US community oncology setting.
    Panjabi, Sumeet
    Medhekar, Rohan
    Aguilar, Kathleen
    Wilson, Thomas
    Amirian, E. Susan
    Mezzi, Khalid
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Patients with Crohn's disease treated with ustekinumab vs. vedolizumab in real-world settings
    Chiorean, M.
    Jiang, J.
    Candela, N.
    Chen, G.
    Romdhani, H.
    Latremouille-Viau, D.
    Shi, S.
    Bungay, R.
    Fan, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S630 - S630
  • [34] WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH SEVERE ASTHMA TREATED WITH MEPOLIZUMAB IN A REAL-WORLD SETTING
    Alfonso-Cristancho, R.
    Canonica, W.
    Price, R. G.
    Yang, S.
    Jakes, R. W.
    Maxwell, A.
    Howarth, P.
    VALUE IN HEALTH, 2022, 25 (07) : S567 - S567
  • [35] Cost-Effectiveness of Late Endovascular Thrombectomy vs. Best Medical Management in a Clinical Trial Setting and Real-World Setting
    Ospel, Johanna Maria
    Zerna, Charlotte
    Harrison, Emma
    Kleinig, Timothy J.
    Puetz, Volker
    Kaiser, Daniel P. O.
    Graham, Brett
    Yu, Amy Y. X.
    van Adel, Brian
    Shankar, Jai J.
    McTaggart, Ryan A.
    Pereira, Vitor
    Frei, Donald F.
    Kunz, Wolfgang G.
    Goyal, Mayank
    Hill, Michael D.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024,
  • [36] Real-World Safety and Effectiveness of Omalizumab in Moderate to Severe Allergic Asthma Patients in China: A Post-Authorization Study
    Su, Nan
    Zhi, Lili
    Liu, Fengxia
    Wang, Yongsheng
    Zhang, Qingling
    Liu, Xiansheng
    Wang, Xueyan
    Hao, Guodong
    Zhang, Xiuqin
    Hu, Qiang
    Ligueros-Saylan, Monica
    Uddin, Alkaz
    Yang, Jing
    Liang, Tiantian
    Ding, Liju
    Li, Runqin
    Wang, Chen
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 625 - 636
  • [37] REAL-WORLD COMPARISONS OF CLINICAL CHARACTERISTICS AND MEDICATION UTILIZATION PRE- AND POST-OMALIZUMAB INITIATION IN ASTHMA PATIENTS
    Huang, Q.
    Kavati, A.
    Ke, X.
    Wertz, D.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S52
  • [38] Real-world effectiveness of omalizumab in allergic asthma patients with low or high blood eosinophils: A retrospective claims analysis study
    Hanania, Nicola A.
    Fang, Juanzhi
    Wei, Zhongyuan
    Ortiz, Benjamin
    Kavati, Abhishek
    Jaumont, Xavier
    Alvares, Luisa
    Cao, Hui
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [39] Demographic Characteristics of Patients Who Utilize Biologics for Severe Asthma: A Real-World European Perspective
    Valliant, S.
    Zhang, S.
    Harvey, J.
    Mu, G.
    Jakes, R.
    Emeanuru, K.
    Palhares, K. Bruini Pitta
    Andre, M.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [40] The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study
    Siracka, Simona
    Tinkova, Lenka Dziva
    Hochmuth, Ludek
    Lescisinova, Helena
    Hrubisko, Martin
    Dostalova, Katarina
    Jesenak, Milos
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (01): : 134 - 141
12345